Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Assembly Biosciences Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
ASMB
Nasdaq
8731
https://www.assemblybio.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Assembly Biosciences Inc
Are Medical Stocks Lagging ASLAN Pharmaceuticals (ASLN) This Year?
- Apr 9th, 2024 1:40 pm
Assembly Biosciences Reports Fourth Quarter and Year End 2023 Financial Results and Recent Highlights
- Mar 28th, 2024 8:05 pm
Assembly Biosciences Announces Effective Date of Reverse Stock Split
- Feb 8th, 2024 1:00 pm
This Assembly Biosciences Insider Increased Their Holding In The Last Year
- Jan 15th, 2024 1:24 pm
Assembly Biosciences Provides Anticipated Development Milestones for 2024
- Jan 4th, 2024 1:00 pm
Assembly Biosciences Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
- Nov 10th, 2023 9:05 pm
Assembly Biosciences Presents New Data Highlighting Viral Hepatitis Portfolio at AASLD The Liver Meeting®
- Nov 10th, 2023 1:00 pm
Assembly Biosciences Reports Third Quarter 2023 Financial Results and Recent Updates
- Nov 8th, 2023 9:05 pm
Assembly Biosciences Names Anuj Gaggar, MD, PhD, as Chief Medical Officer
- Nov 8th, 2023 1:00 pm
Gilead and Assembly Biosciences Establish Partnership to Develop Next-Generation Therapeutics for Serious Viral Diseases
- Oct 17th, 2023 11:00 am
Assembly Biosciences to Present New Data at AASLD The Liver Meeting®
- Oct 11th, 2023 12:00 pm
Assembly Biosciences Nominates Development Candidate ABI-6250, an Orally Bioavailable HDV Entry Inhibitor
- Oct 2nd, 2023 12:00 pm
Assembly Biosciences to Highlight Pipeline Progress in HBV and HDV at the 2023 International HBV Meeting
- Sep 19th, 2023 8:05 pm
We're A Little Worried About Assembly Biosciences' (NASDAQ:ASMB) Cash Burn Rate
- Sep 6th, 2023 2:58 pm
Assembly Biosciences Reports Second Quarter 2023 Financial Results and Recent Updates
- Aug 9th, 2023 8:05 pm
Assembly Biosciences Presents New Data Highlighting Herpes Simplex Virus Development Candidate ABI-5366 at the 47th Annual International Herpesvirus Workshop
- Jul 17th, 2023 12:00 pm
Assembly Biosciences Presents New Data Highlighting Entry Inhibitor and Core Inhibitor Programs at EASL’s International Liver Congress™ 2023
- Jun 21st, 2023 12:00 pm
Assembly Biosciences to Present Data at Upcoming International Herpesvirus Workshop and EASL International Liver Congress™ 2023
- Jun 7th, 2023 12:00 pm
Assembly Biosciences to Present During the 2023 Jefferies Healthcare Conference
- May 23rd, 2023 8:05 pm
Assembly Biosciences Reports First Quarter 2023 Financial Results and Recent Highlights
- May 4th, 2023 8:05 pm
Scroll